Home/Filings/4/0001628280-25-033754
4//SEC Filing

Liu David R. 4

Accession 0001628280-25-033754

CIK 0001894562other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 4:03 PM ET

Size

5.2 KB

Accession

0001628280-25-033754

Insider Transaction Report

Form 4
Period: 2025-06-30
Liu David R.
10% Owner
Transactions
  • Purchase

    Common Stock

    2025-06-30$2.52/sh+21,000$52,83020,240,945 total
Footnotes (2)
  • [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025.
  • [F2]The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.44 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

Prime Medicine, Inc.

CIK 0001894562

Entity typeother

Related Parties

1
  • filerCIK 0001664439

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:03 PM ET
Size
5.2 KB